Baseline history of patients using selexipag for pulmonary arterial hypertension

INTRODUCTION: Since its introduction to the market in 2016, selexipag has been an alternative oral therapy among both treatment-naïve patients and those with mono or dual therapy failure; however, limited information is available regarding the presentation and management of patients with pulmonary a...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Ther Adv Respir Dis
Asıl Yazarlar: Highland, Kristin B., Hull, Michael, Pruett, Janis, Elliott, Caitlin, Tsang, Yuen, Drake, William
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: SAGE Publications 2019
Konular:
Original Research
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6466463/
https://ncbi.nlm.nih.gov/pubmed/30983530
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1753466619843774
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller